Here’s why so few drug candidates in animal trials end up as human therapies.
Academic rigor, journalistic flair
Articles on Hype
Displaying all articles
The recent declines of Threads and ChatGPT attest to the reality that rapid and widespread acceptance doesn’t necessarily lead to long-term success.
CBD isn’t a miracle cure for everything that ails a person – but science shows that it has the potential to help treat a number of health conditions.
When lockdowns went into effect earlier this year, interest in massive online open courses, or MOOCs, began to surge. An expert expects the interest to continue.
Prominent thinkers exaggerating the potential or danger of artificial intelligence are pushing us towards a new AI winter.
The enthusiasm for business creation is not without negative consequences, especially for the many who fail. However, the “all entrepreneurs” discourse remains predominant.
The history of human-machine collaboration suggests that AI will evolve into a “cognitive partner” to humankind rather than as all-powerful, all-knowing, labour replacing robots.
Many of the online testimonials you might read for dentists and other health professional can not only mislead, they can be illegal.
Social media is a great way to spread science information, fast. But the online echo chamber isn’t always good at separating what’s valid from what’s not, and being prolific doesn’t make you right.
Top contributors
-
Omar H. Fares is a Friend of The Conversation.Lecturer of Marketing in the Lazaridis School of Business and Economics, Wilfrid Laurier University
-
Professor and Associate Dean of Engagement & Inclusion, Ted Rogers School of Management, Toronto Metropolitan University
-
University Distinguished Professor of Astronomy, University of Arizona
-
Associate Professor, Emerging Media Studies, Boston University
-
Professeur de Sociologie, Chercheur au Centre Maurice Halbwachs ENS/EHESS/CNRS , professeur de sociologie, AgroParisTech – Université Paris-Saclay
-
Master's Student in Emerging Media Studies, Boston University
-
Clinical Professor, University of Sydney
-
Head of the Marketing Innovation and Distribution Program at EMLV, Pôle Léonard de Vinci
-
Distinguished Visiting Professor of Economics, University of Johannesburg
-
Professor of Biostatistics and Epidemiology, University of South Australia
-
Professor and Chair of Pharmacology, Penn State
